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Abstract
Background: Epigenetic processes play a key role in orchestrating transcriptional regulation during the development
of the human central nervous system. We previously described dynamic changes in DNA methylation (5mC) occurring
during human fetal brain development, but other epigenetic processes operating during this period have not been
extensively explored. Of particular interest is DNA hydroxymethylation (5hmC), a modification that is enriched in the
human brain and hypothesized to play an important role in neuronal function, learning and memory. In this study, we
quantify 5hmC across the genome of 71 human fetal brain samples spanning 23 to 184 days post-conception.
Results: We identify widespread changes in 5hmC occurring during human brain development, notable sex-differences
in 5hmC in the fetal brain, and interactions between 5mC and 5hmC at specific sites. Finally, we identify loci where 5hmC
in the fetal brain is associated with genetic variation.
Conclusions: This study represents the first systematic analysis of dynamic changes in 5hmC across human
neurodevelopment and highlights the potential importance of this modification in the human brain. A searchable
database of our fetal brain 5hmC data is available as a resource to the research community at http://www.
epigenomicslab.com/online-data-resources.
Background
Human brain development is characterized by coordi-
nated changes in gene expression mediated by a complex
interaction between transcription factors [1] and epigen-
etic processes [2]. We recently characterized the dramatic
alterations in DNA methylation (5-methylcytosine, 5mC)
occurring during human neurodevelopment [3], but little
is known about the role of other epigenetic modifications
during this period. Of particular interest is DNA hydroxy-
methylation (5-hydroxymethylcytosine, 5hmC), a covalent
modification of cytosine that represents an oxidised
derivative of 5mC produced by the process of active DNA
demethylation [4, 5]. Of note, 5hmC is present at relatively
high levels in the mature central nervous system [6], and
particularly enriched in the vicinity of genes with synapse-
related functions [7]. Although initially hypothesized to
represent an intermediate step of the DNA demethylation
pathway, 5hmC is now assumed to have specific func-
tional roles in the brain. Several specific molecular readers
of 5hmC have been identified, including transcriptional
regulators, chromatin modifiers and DNA damage and
repair proteins [8–12]. Additionally, the ten-eleven trans-
location (TET) family of proteins that catalyze the conver-
sion of 5mC into 5hmC have been implicated in neuronal
differentiation and function [13]; studies manipulating
TET activity suggest that 5hmC plays a role in learning
and memory, hippocampal neurogenesis, and neuronal
activity-regulated gene expression [14–16]. Recently,
5hmC has been found to mark regulatory regions of the
genome in the murine and human fetal brain [2, 17] and
increase rapidly in abundance postnatally, concurrent with
neuronal maturation and synaptogenesis [18–20]. Notably,
there is growing evidence to suggest that abnormal regula-
tion of 5hmC contributes to the etiology of several neuro-
developmental disorders including autism spectrum
disorders [21] and schizophrenia [22].
Importantly, many of the standard methods used to
quantify 5mC, including those based on sodium bisulfite
(BS) conversion of DNA, are unable to discriminate
between 5mC and 5hmC [10, 23], with important implica-
tions for the interpretation of published DNA methylation
datasets from brain. Recently, a number of methods have
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been developed to enable the quantification of 5hmC
across the genome [24]. Oxidative bisulfite (oxBS) conver-
sion of genomic DNA, which involves the oxidation of
5hmC to 5-formylcytosine (5fC) prior to standard BS
conversion, enables the accurate quantification of 5mC,
allowing 5hmC to be measured by proxy at base-pair
resolution [25–27]. In this study, we use this approach in
combination with the Illumina 450 K HumanMethylation
array (“450 K array”) to undertake the first systematic
study of 5hmC in the developing human brain, profiling
71 fetal samples ranging from 23 to 184 days post-
conception (DPC). We identify widespread changes in
5hmC during human brain development, with differentially
hydroxymethylated positions (DHPs) and regions (DHRs)
becoming both hyper- and hypo-hydroxymethylated with
fetal age. As a resource to the scientific community a
searchable database of our fetal brain 5hmC data is
available at http://www.epigenomicslab.com/online-data-
resources.
Results
Autosomal distribution of 5hmC in the developing human
brain
We quantified 5hmC across the genome by subtracting
oxBS-generated 450 K array profiles from those gener-
ated following BS-conversion performed in parallel
(ΔβBS-oxBS). We set a stringent threshold for calling 5hmC
(ΔβBS-oxBS > 0.036) based on the 95th percentile of nega-
tive ΔβBS-oxBS values across all profiled samples, with sites
below this threshold characterized as having “undetect-
able” 5hmC (see Methods section). Consistent with previ-
ous observations in young neurons [18, 19, 28], we
observed overall low levels of global 5hmC in the fetal
brain (mean level of 5hmC across all 411,325 probes pass-
ing our stringent quality-control metrics = 2.97%
(SD = 5.16%)). Approximately a quarter (n = 103,063
(25.64%)) of all autosomal probes included in the ana-
lysis were characterized by non-detectable 5hmC (i.e.
ΔβBS-oxBS < 0.036) in all 71 fetal brain samples exam-
ined (Fig. 1a and Additional file 1: Table S1); these
sites were significantly enriched in CpG islands and
other promoter regulatory regions including the
transcription start-site (TSS), 5’UTR and 1st Exon
(Additional file 1: Table S2). In contrast, a small
number of autosomal sites (n = 5061 (1.26%)) were
characterized by detectable 5hmC in all 71 samples;
these sites were significantly enriched in CpG island
shores and shelves, regions flanking the TSS and gene
bodies (Additional file 1: Table S2). Of these consist-
ently hydroxymethylated probes a large proportion
were also characterized by detectable 5hmC in our
previous analysis of a small number of adult cortex
(n = 2162, 43%) and cerebellum (n = 2381, 47%)
samples [27]. Notably, the majority of probes were
characterized by detectable 5hmC in only a subset of
samples (Fig. 1a), indicating that the presence and
distribution of 5hmC is highly variable during fetal
brain development.
Across the 298,972 autosomal probes (74.36%) charac-
terized by detectable 5hmC (i.e. ΔβBS-oxBS > 0.036) in at
least one fetal brain sample, the mean level of 5hmC
was 4.16% (SD 5.43%) across all fetal brain samples
(Additional file 1: Table S3). In agreement with previous
studies [27, 29–32], we observed an inverse relationship
between CpG density and mean levels of 5hmC at these
sites, with significantly lower levels in CpG islands
(1.56%, P-value <1.00E-200) and higher levels in sites
not located within CpG islands, shores or shelves
(5.20%, P-value <1.00E-200) compared to the average
across all sites characterized by detectable 5hmC in at
least one fetal brain sample (Additional file 2: Figure S1;
Additional file 1: Table S3). 5hmC was significantly
enriched at 450 K array probes in gene bodies (4.37%,
P-value <1.00E-200) and 3’UTRs (4.74%, P-value
<1.00E-200), and significantly depleted at 450 K array
probes located within 1500 bp (3.93%, P-value <1.00E-
200) and 200 bp (2.14%, P-value <1.00E-200) upstream
of the transcription start site (TSS), 5’UTRs (3.85%, P-value
<1.00E-200), and 1st exons (2.24%, P-value <1.00E-200)
(Additional file 2: Figure S1; Additional file 1: Table S3),
concurring with previous observations [19, 27, 29–31].
Human fetal brain development is associated with dynamic
changes in 5hmC at specific loci
Our previous study quantified BS-converted DNA to
identify changes in total DNA modifications (i.e. 5mC
and 5hmC) across fetal brain development in an
overlapping set of fetal brain samples [3], and was there-
fore not able to distinguish between 5mC and 5hmC.
For the developmentally differentially modified positions
(dDMPs) identified in our original study that were
included in our final dataset (n = 28,330 probes), we
found a highly-significant correlation of effect sizes
across both BS datasets (r = 0.99; P-value <1.00E-200)
(Additional file 2: Figures S2 and S3), confirming the
robust nature of our previous DNA modification esti-
mates. We explored the extent to which changes at these
sites, previously attributed to changes in 5mC, were
confounded by levels of 5hmC. There was a strong cor-
relation (r = 0.97, P-value <1.00E-200) between the BS
(5mC + 5hmC) and oxBS (5mC) effect sizes (Additional
file 2: Figure S4) at these sites, indicating that the DNA
modification dynamics previously described [3] are likely
to primarily reflect changes in 5mC. The majority of
these sites (n = 28,255, 99.74%), however, were charac-
terized by detectable 5hmC in at least one sample and
there was a significant positive correlation (r = 0.36;
P-value <1.00E-200) (Additional file 2: Figure S5) between
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the BS (5mC + 5hmC) and BS-oxBS (5hmC) effect sizes,
indicating a contribution of dynamic 5hmC across brain
development at these sites.
We next used a linear model to detect sites where
levels of 5hmC changed across brain development (see
Methods), identifying 62 developmentally differentially
hydroxymethylated positions (dDHPs) at a stringent
Bonferroni-corrected significance threshold (P-value
<1.67E-07) (Additional file 1: Table S4), representing
0.02% of the 298,972 autosomal probes tested. At a more
relaxed “discovery” significance threshold (P-value <5E-
05), we identified 2181 sites (0.73%) characterized by
b
a
d
c
Fig. 1 5hmC is highly dynamic across human fetal brain development. a The presence or absence of detectable 5hmC at individual sites is highly
variable amongst the fetal brain samples profiled in this study. Shown is the proportion of probes with detectable 5hmC as a function of the fetal brain
samples profiled. Only a small number of probes are characterized by ubiquitously detectable 5hmC in all samples, highlighting considerable inter-individual
heterogeneity at individual probes. b The top-ranked dDHP characterized by increasing 5hmC with days post-conception (DPC) is cg25069807, annotated
to TK1 on chromosome 17 (P = 2.52E-09). c The top-ranked dDHP characterized by decreasing 5hmC with brain development is cg22960621, annotated to
NLGN1 on chromosome 3 (P = 1.42E-09). Males are depicted in black. The dashed line indicates values above which 5hmC is considered to be reliably
detected (ΔβBS-oxBS > 0.036). The full list of 2181 dDHPs (P < 5.00E-05) is presented in Additional file 1: Table S5. d The top-ranked dDHR associated with fetal
brain development spans a 685 bp region (Chr22: 46,449,430–46,450,115) encompassing the first exon of C22orf26 and LOC150381. The dDHR is denoted by
dashed vertical lines. Chromosomal coordinates correspond to human genome build GRCh37/hg19. See Additional file 1: Table S8 for a full list of dDHRs
associated with human brain development
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changes in 5hmC during brain development (Additional
file 1: Table S5). The top-ranked sites characterized by
increasing 5hmC across brain development (henceforth
referred to as hyperhydroxymethylated dDHPs) and
decreasing 5hmC across brain development (henceforth
referred to as hypohydroxymethylated dDHPs) are
shown in Fig. 1b and c, respectively. Among the “discovery”
dDHPs we observed a significant enrichment of hypohy-
droxymethylated autosomal dDHPs (n = 1278 (58.60%))
compared to hyperhydroxymethylated dDHPs (n = 903
(41.40%)) (enrichment hyperhydroxymethylated OR = 0.71,
P-value = 1.29E-08) (Additional file 1: Table S6). We next
used comb-P [33] to identify spatially correlated regions of
developmentally dynamic 5hmC (or developmentally
differentially hydroxymethylated regions (dDHRs)). A total
of 254 dDHRs (Šidák-corrected P-value <0.05) were identi-
fied, spanning an average of 5.43 probes and 551.30 base
pairs (SD = 362.97) (Additional file 1: Table S7). The
top-ranked dDHR, encompassing 11 CpG sites spanning
the first exon of C22orf26 and LOC150381 on chromosome
22, is characterized by a significant reduction in 5hmC
across brain development (Šidák-corrected P-value = 1.10E-
15) (Fig. 1d). A full list of dDHRs is presented in Additional
file 1: Table S8.
Sites characterized by changes in 5hmC across brain
development are not distributed equally across genomic
features
Although the frequency of dDHPs is relatively consistent
across autosomes, chromosome 19 is notably depleted of
dDHPs (relative enrichment = 0.62, P-value = 3.08E-05)
(Additional file 1: Table S9). The distribution of dDHPs,
however, is not equal across annotated genic features
(Additional file 1: Tables S6 and S10), being significantly
depleted in promoter regulatory regions, including
CpG islands (percentage of significant probes = 0.32%,
relative enrichment = 0.43, P-value = 1.43E-33), and
enriched at sites not annotated to CG-rich features
(CpG islands, shores and shelves) (percentage of
significant probes = 0.92%, relative enrichment = 1.26, P-
value = 2.27E-10) (Additional file 2: Figures S6 and S7).
There is also a significant enrichment of dDHPs in
annotated DNase I hypersensitivity sites (percentage of
significant probes = 0.96%, relative enrichment 1.32, P–
value = 2.62E-13) (Additional file 1: Table S6) and probes
associated with transcription factor binding sites (TFBSs)
[34] (percentage of significant probes = 0.79%, relative
enrichment = 1.09, P-value = 4.41E-02), with specific
TFBS motifs being specifically enriched for dDHPs
(Additional file 1: Table S11). Sites associated with specific
alternative transcription event domains were significantly
depleted for dDHPs (Additional file 2: Figure S8;
Additional file 1: Table S12) including alternative 3′ splice
sites (percentage of significant probes = 0.34%, relative
enrichment = 0.46, P-value = 1.51E-02) and constitutive
exons (percentage of significant probes = 0.44%, relative
enrichment = 0.59, P-value = 4.70E-06).
There is a complex relationship between 5mC and 5hmC
across human brain development
It is not yet definitively known whether 5hmC represents
a stable or transient DNA modification [35] and its
relationship to 5mC has not been explored in a large
number of samples. Our data show that levels of 5hmC
in the fetal brain are highest at loci characterized by
intermediate levels of 5mC (Fig. 2a), concurring with the
results of previous analyses [27, 30]. To further delineate
the relationship between 5mC and 5hmC during brain
development we compared effect sizes (regression coeffi-
cients reflecting change in DNA modification with
development) for all dDHPs passing our ‘discovery’
significance threshold (n = 2181) (Fig. 2b). dDHPs could
be split into three broad groups; one characterized by
changes in 5mC paralleling those seen for 5hmC (e.g.
Fig. 2c-d), a second where changes occurred in the
opposite directions across the two DNA modifications
(e.g. Fig. 2e-f ), and a third characterized by changes in
5hmC, but no changes in 5mC (e.g. Fig. 2g). Of note,
nearly half (n = 1059; 48.56%) of the dDHPs tested
where characterized by a significant interaction (P-value
<2.29E-05) between trajectories of 5mC and 5hmC
across brain development (Fig. 2b).
Sex differences in the human fetal brain
hydroxymethylome
Although the majority of autosomal chromosomes are
characterized by a similar mean level of 5hmC
(Additional file 1: Table S13) (mean 5hmC across
298,972 autosomal probes = 4.16%), levels are signifi-
cantly lower on the X-chromosome (mean 5hmC = 2.00%,
P-value <1.00E-200), especially in females (mean 5hmC
across X-chromosome in females = 1.40%, P-value
<1.00E-200). A total of 427 probes (0.14% of the 307,810
autosomal and X-linked probes assessed) displayed
significantly different levels of 5hmC between male and
females (Bonferroni-significance level of P-value <1.62E-
07), all located on the X-chromosome (Fig. 3a). In
contrast to 5mC, however, which is elevated on the in-
active female X-chromosome, the majority of these sites
(n = 404; 94.61%) were characterized by a higher level of
5hmC in males (Fig. 3b and c and Additional file 2:
Figure S9). Higher 5hmC in males versus females is
observed across canonical gene features on the X-
chromosome, however this is not seen on the autosomes
(Fig. 3d). A total of 144 fetal brain DHRs were identified
between males and females using comb-P (Šidák-corrected
P-value <0.05, number of probes ≥ 3) (Additional file 1:
Table S14). All were located on the X-chromosome and
Spiers et al. BMC Genomics  (2017) 18:738 Page 4 of 14
ac d
e
g
f
b
Fig. 2 (See legend on next page.)
Spiers et al. BMC Genomics  (2017) 18:738 Page 5 of 14
the top-ranked sex-associated DHR is shown in
Additional file 2: Figure S10.
Modules of co-hydroxymethylated loci are identified in
the developing human brain
We next employed weighted gene co-hydroxymethylation
network analysis (WGCNA) [36] to undertake a systems
level characterization of the 5hmC changes associated
with human brain development. WGCNA identified a
total of 32 discrete modules of co-hydroxymethylated sites
(Additional file 1: Table S15). The first principal compo-
nent of each module, the “module eigengene”, was used to
assess the module relationship with fetal brain develop-
ment (Fig. 4a). Seven modules were significantly corre-
lated with brain development (P-value <1.56E-03)
(Additional file 1: Table S15; Fig. 4b; Additional file 2:
Figure S11). Module membership within these modules
was highly correlated with probe significance (Additional
file 2: Figure S12), indicating a clear relationship between
5hmC at the core members of each module and fetal brain
development (Fig. 4c). To assess whether these modules
are biologically meaningful, functional enrichment
analyses were performed on the top 1000 probes from
the seven DPC-associated modules (Additional file 1:
Table S16). Highly significant gene ontology (GO)
terms were identified for the DPC associated modules
including “dendrite morphogenesis” (“blue” module; P-
value = 3.22E-11), “negative regulation of synaptic trans-
mission” (“black” module; P-value = 6.29E-09), “negative
regulation of axon extension involved in axon guidance”
(“red” module; P-value = 3.64E-09) and “embryonic organ
morphogenesis” (“green” module, P-value = 1.79E-11),
suggesting that the large changes in 5hmC across fetal
brain development contribute to the regulation of relevant
biological processes. Additionally, the sex-associated
“lightcyan” module was significantly enriched for terms
relevant to brain development including “dendritic spine
development” (P-value = 8.86E-05), suggesting that sex
differences in 5hmC may contribute to sex-specific neuro-
developmental processes.
DNA hydroxymethylation quantitative trait loci
Building on our recent work identifying genetic effects
on 5mC in the fetal brain [37], we explored genetic
influences on levels of 5hmC by performing a genome-
wide scan for 5hmC quantitative trait loci (hmQTL). Al-
though we were not highly-powered to detect hmQTLs
given the relatively small sample size and relative paucity
of 5hmC, we identified 23 hmQTLs at a Bonferroni
significance threshold (P-value <2.2E-13) associated with
5hmC with a median effect size of 6.99% per allele
(Additional file 1: Table S17, Fig. 5), and 77 hmQTLs at
a more relaxed discovery threshold of P-value <1E-11
(Additional file 1: Table S18). In contrast, we identified
13,480 mQTLs at a Bonferroni significance threshold (P-
value <1.6E-13) for 493 distinct sites, and 24,286 mQTLs
at a discovery threshold of P-value <1E-11 at 860
distinct sites, in the same samples, reflecting the higher
abundance of methylated sites in the genome. Three
sites were part of 11 Bonferroni significant QTLs for
both modifications, all showing the same direction of ef-
fect. Of the 13,480 mQTL identified 1383 (10.3%) were
associated with probes that did not show any detectable
levels of 5hmC, and 7652 (56.8%) showed no evidence of
a genetic effect on 5hmC (P-value >0.05). 11,910 (98.5%)
mQTLs were associated with significant (P-value <0.05/
12,097) heterogeneous genetic effects across 5mC and
5hmC.
Discussion
In this study, we examined neurodevelopmental changes
in 5hmC in 71 human fetal brain samples spanning 23
to 184 DPC. To our knowledge, this represents the most
extensive study of 5hmC in the human brain and is the
first to examine changes in 5hmC across human neuro-
development. We identify highly significant changes in
5hmC during human brain development at multiple
sites, and modules of co-hydroxymethylated loci associ-
ated with fetal age that are significantly enriched in the
vicinity of genes involved in neurodevelopmental
processes. We highlight a complex relationship between
patterns of 5hmC and 5mC across brain development;
while some loci are characterized by parallel changes in
both modifications, other sites are characterized by
opposite patterns. Strikingly, in contrast to 5mC, levels
of 5hmC on the X-chromosome are lower in females
than males. Finally, although hmQTLs are considerably
less widespread than mQTLs in the fetal brain, we
(See figure on previous page.)
Fig. 2 There is a complex interaction between 5hmC and 5mC across human brain development. a DNA hydroxymethylation levels are highest
at sites characterized by intermediate levels of DNA methylation. Mean DNA hydroxymethylation versus mean DNA methylation is shown for all autosomal
probes included in the final dataset (n = 298,972). b Scatterplot showing the regression coefficients for 5hmC and 5mC for each of the 2181 dDHPs
(P < 5.00E-05). Nearly half of the dDHPs (n = 1059, 48.56%) are characterized by a significant interaction (P < 2.29E-05) between 5hmC and 5mC across
brain development (significant sites are shown in red). Examples of sites at which fetal brain development is associated with (c) increases in both 5hmC
and 5mC, (d) decreases in both 5hmC and 5mC, (e) an increase in 5mC but a decrease in 5hmC, (f) a decrease in 5mC but an increase in 5hmC and (g) a
change in 5hmC but no alteration in 5mC. 5mC data shown as diamonds, 5hmC data shown as circles. Male samples are indicated by a filled diamond
or circle
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Fig. 3 Levels of 5hmC in the human fetal brain are significantly lower on the X-chromosome in females than males. a Manhattan plot showing
the distribution of sites characterized by different levels of 5hmC between males and females. P-value corresponds to association with sex. Points above
the X-axis indicate higher 5hmC in females, with those below the X-axis indicating higher 5hmC in males. The red line represents a Bonferroni-corrected
significance threshold (P < 1.62E-07) for the 307,810 autosomal and X chromosome probes analyzed. The blue line corresponds to our “discovery” P-value
threshold (P < 5E-05). b The top-ranked sex-associated DHP characterized by greater 5hmC in males is cg07806797, annotated to ZNF185 on the X-
chromosome (P = 7.19E-20). c The top-ranked sDHP characterized by greater 5hmC in females is cg2678647, annotated to USP11 on the X-chromosome
(P = 3.64E-16). d Mean 5hmC across canonical gene features is shown for males and females (pink and blue, respectively) for autosomes (top panel) and
the X-chromosome (bottom panel)
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highlight examples where 5hmC is associated with
genetic variation.
Consistent with previous observations in young
neurons [18, 19, 28], we observe overall low levels of
global 5hmC in the human fetal brain. Examining the
genomic distribution of 5hmC highlighted an inverse
correlation between mean 5hmC and CpG density, with
a depletion of 5hmC in promoter regions and enrich-
ment in gene bodies, relative to global 5hmC levels, con-
cordant with previous observations in adult human
brain [2, 19, 29–31, 38]. The chromosomal distribution
of 5hmC was relatively consistent, although a depletion
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Fig. 4 Modules of co-hydroxymethylated loci in the developing human brain. a Heat-map representing the correlation between module eigenvalues (ME)
and the samples traits of fetal age (DPC) and sex. Each row represents a module, as indicated on the y-axis, and each column a trait. As shown in the color
scale bar, strong positive correlation is indicated by dark red, strong negative correlation is indicated by dark green, and white indicates no correlation. Each
cell contains the corresponding correlation and P-value given in parentheses (see also Additional file 1: Table S15). b Shown is the association between the
ME and DPC for the top-ranked co-hydroxymethylated modules associated with brain development. The ‘brown’ module is the most positively associated
with human fetal brain development (corr = 0.60, P = 3E-08). The ‘blue’ module is the most negatively associated with human brain development
(corr = −0.48, P = 3E-05). c Heat-map of the top 1000 probes ranked by module membership in the ‘brown’ and ‘blue’ modules, showing coordinated
changes in 5hmC across brain development. Color corresponds to the level of 5hmC at each probe
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of 5hmC was found on the X-chromosome relative to
autosomes in both males and females, and this deficit
was particularly striking in females. These data concur
with previous studies reporting a deficit in X-
chromosome 5hmC [2, 19, 29], suggesting a possible role
in dosage compensation for X-linked genes. Interest-
ingly, there was reduced X-chromosome 5hmC in
females compared to males, in stark contrast to 5mC
which is associated with silencing of the inactive allele.
5hmC is hypothesized to be associated with transcrip-
tionally permissive chromatin states; whilst 5mC is often
associated with gene repression, 5hmC facilitates
transcription through contributing to open chromatin
[39, 40]. During synaptogenesis, for example, while 5mC
accumulates in heterochromatin, 5hmC becomes enriched
in euchromatin, consistent with its co-localization with
PolII which mediates RNA transcription [20]. Interest-
ingly, the male X-chromosome was also characterized by
lower 5hmC than the autosomes, suggesting that even the
active X-chromosome is characterised by relatively low
levels of this modification.
It has not yet been fully established whether 5hmC is a
stable epigenetic mark that contributes to the regulation
of genomic function, or whether it is a transient
intermediate marking sites of active demethylation. Our
analysis of the relationship between 5mC and 5hmC
across brain development in the same samples revealed
a complex relationship at individual probe sites. At a
number of loci, levels of 5hmC increased or decreased in
parallel with 5mC, although other locations were charac-
terized by changes in the opposite direction during brain
development. This stable accumulation or depletion of
5hmC at specific sites suggests it may not merely
represent a transient intermediate of active DNA
demethylation, providing further evidence to support a
functional role for this modification in brain develop-
ment. Alternatively, it is possible that the patterns we
observe reflect differences in the regulation of demethyl-
ation at different sites.
There are several limitations to this study that should
be considered. First, although this represents the first
systematic analysis of 5hmC across multiple stages of
human fetal brain development, legal restrictions on
later-term abortions precluded the assaying of brain
samples from later stages. Second, because the brain
tissue was acquired frozen it was processed as a composite
Fig. 5 Examples where 5hmC at specific sites is influenced by genetic variation. a Genetic variation at rs11018924 influences both 5hmC
(P = 4.67E-15) and 5mC (P = 9.73E-15) at cg26138821 in the fetal brain, with both modifications being positively associated with the
minor allele (G). b Genetic variation at rs2788655 influences both 5hmC (P = 6.88E-12) and 5mC (P = 1.20E-10) at cg10523679, with both
modifications positively associated with the minor allele (A)
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of brain regions and cell types and our data should there-
fore be seen as reflecting predominant changes in the
developing human brain as a whole. Of note, however, all
samples were classified as being human prefrontal cortex
using an online tissue prediction algorithm developed by
Steven Horvath that uses DNA methylation data to infer
tissue type (https://labs.genetics.ucla.edu/horvath/dna-
mage/) [41]. Third, although the Illumina 450 K platform
provides accurate quantification at single-base resolution
with probes associated with 99% of genes and 96% of
CGIs, the array targets <2% of the CpG sites in the human
genome, and probes are not equally distributed across all
genomic features. To calculate 5hmC it is necessary to
run two arrays per sample (following BS- and oxBS-
conversion), potentially increasing technical variability.
However, we found a very strong concordance between
the BS-converted DNA data and our previous study of
total DNA modifications in the fetal brain. This study also
highlights the potential for 5hmC to confound DNA
modification data produced using BS-converted DNA, the
standard method for profiling 5mC. As costs reduce,
future studies can apply sequencing-based genomic profil-
ing technologies to more thoroughly interrogate DNA
modifications across the genome. To provide insight re-
garding the cause and functional consequences of epigen-
etic developmental dynamics, future studies should take a
multi-omic approach and integrate genomic, transcrip-
tomic and proteomic data sets; in particular, it will be
important to integrate data about other epigenetic
marks, including alternative DNA modifications (i.e.
5-fluorocytosine and 5-carboxylcytosine) and histone
modifications with our 5mC and 5hmC data.
Conclusions
We identify dynamic changes in 5hmC occurring
throughout the genome during human fetal brain
development. There are discrete modules of co-
hydroxymethylated loci associated with brain develop-
ment that are significantly enriched for genes involved
in neurodevelopmental processes. There is a complex
relationship between levels of 5mC and 5hmC across
brain development, with notable sex differences on the
X-chromosome. Finally, we show that 5hmC at specific
loci is associated with genetic variation. Together, these
data further highlight the role of dynamic epigenetic
processes during brain development, with potential im-
plications for understanding the origins of neurodeve-
lopmental health and disease.
Methods
Methodological overview
DNA modifications (DNA methylation (5mC) and DNA
hydroxymethylation (5hmC)) were assessed in 72 human
fetal brain samples (36 male; 36 female), spanning 23 to
184 days post-conception (DPC). Genomic DNA was
isolated from fetal brain tissue acquired frozen from the
Human Developmental Biology Resource (HDBR)
(http://www.hdbr.org) and MRC Brain Banks Network
(https://www.mrc.ac.uk/research/facilities-and-resources-for-
researchers/brain-banks/) under strict ethical regulations, as
previously described [3]. DNA modifications and DNA
methylation were quantified with the Illumina Infinium
HumanMethylation450 BeadChip, as previously described
[27, 42]. Two pre-treatments, BS and oxBS conversion, and
two Illumina 450 K arrays were run for each sample. Follow-
ing quality control procedures, preprocessing and normalisa-
tion, as previously described [42], DNA modification and
DNA methylation beta values were generated, and a
DNA hydroxymethylation value calculated from these
measures. An overview of the method for the quanti-
fication of DNA hydroxymethylation is provided in
Additional file 2: Figure S13.
Human fetal brain samples
Human fetal brain tissue was acquired from the Human
Developmental Biology Resource (HDBR) (http://
www.hdbr.org) and the MRC Brain Banks network
(https://www.mrc.ac.uk/research/facilities-and-resources-
for-researchers/brain-banks/access-for-research/). Ethical
approval for the HDBR was granted by the Royal Free
Hospital research ethics committee under reference 08/
H0712/34 and Human Tissue Authority (HTA) material
storage license 12,220; ethical approval for the MRC Brain
Bank was granted under reference 08/MRE09/38. The de-
velopmental age of each sample was determined using
Carnegie Staging for embryonic (defined as ≤56 DPC)
samples and foot and knee to heel length measurements
for fetal (defined as ≥57 DPC) samples. No additional
phenotypic or demographic information was available for
any of the samples used in this study. An overview of the
samples is given in Additional file 2: Figure S14 and
Additional file 1: Table S19. Genomic DNA was isolated
using standard phenol-chloroform procedures and
quantified using the Qubit® BR dsDNA assay with the
Qubit® Fluorometer (Life Technologies, Thermo Fisher
Scientific). Sample sex was determined via PCR amplifica-
tion of a region near the amelogenin gene (AMELY) that
produces different sized PCR products for the X and Y
chromosomes, (977 and 788 bp, respectively) [43].
Following DNA modification profiling, sex was confirmed
using multidimensional scaling plots of microarray probes
on the X-chromosome.
Quantification of DNA methylation and DNA
hydroxymethylation using the Illumina 450 K array
Samples were randomized with respect to DPC and sex
to avoid batch effects throughout all experimental
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procedures. For each sample two 500 ng aliquots of gen-
omic DNA were subject to parallel oxBS and BS conver-
sion (Additional file 2: Figure S13) using the
TrueMethyl® 24 kit (CEGX, Cambridge, UK). Sample re-
covery was assessed using the Qubit® ssDNA assay, with
a final sample concentration of ≥20 ng/μl considered op-
timal for further analysis. A digestion control assay was
used to qualitatively confirm successful oxBS and BS
conversion (Additional file 2: Figure S15). Total levels of
DNA modification (5mC + 5hmC, BS-converted DNA)
and DNA methylation (5mC, oxBS-converted DNA)
were quantified using the Illumina HumanMethyla-
tion450 BeadChip (Illumina) scanned on an Illumina
HiScan (Illumina). BS- and oxBS-converted DNA sam-
ples from each individual were processed together at all
stages.
Data pre-processing and quality control
GenomeStudio (Illumina) was used to extract signal in-
tensities for each probe, generating a final report that
was imported into the R statistical environment 3.0.2
(http://www.r-project.org) [44] using the methylumi
package (http://www.bioconductor.org/packages/release/
bioc/html/methylumi.html). Sample identity was con-
firmed using multidimensional scaling to confirm con-
cordance between the expected and reported sample
sex, and via correlation of the beta values for the 65
single nucleotide polymorphism (SNP) probes for each
BS- and oxBS-converted sample pair. Data quality con-
trol and preprocessing were performed using the wateR-
melon package as described previously [42]. Stringent
filtering of the prenormalized Illumina 450 K data was
performed using the pfilter function; CpG sites with a
beadcount of <3 in 5% of samples were removed
(n = 838) and CpG sites with a detection P-value >0.05
in 1% of samples (n = 19,163), additionally one sample
having 5% of sites with a detection P-value >0.05 was re-
moved. Finally, cross-reactive probes and polymorphic
CpGs, as detailed in the Illumina annotation file and
identified in recent publications [45, 46] were removed
(Additional file 1: Table S20), leaving 411,325 probes for
initial analysis (including n = 9275 X-chromosome and
n = 15 Y-chromosome probes). Information for samples
included in the final dataset (n = 35 males [age range = 23
to 184 DPC]; n = 36 females [age range = 37 to 161
DPC]) is shown in Additional file 1: Table S19. DNA
modification (BS-converted) and DNA methylation
(oxBS-converted) data were normalized separately using
the dasen method within the wateRmelon package [42].
Plotting the normalised beta density for both the BS-
and oxBS-converted samples revealed a bimodal
distribution for both pre-treatment approaches
(Additional file 2: Figure S16). The BS-converted
samples showed a clear shift to the right of the oxBS-
converted samples, corresponding to combined quantifi-
cation of both 5mC and 5hmC. Normalized beta values
for the oxBS-converted samples (5mC) were subtracted
from the normalized beta values for the corresponding
BS-converted samples (5hm + 5hmC) to calculate a ‘Δ
beta’ value corresponding to the level of DNA
hydroxymethylation at each probe. As expected, the beta
value density distribution was positively skewed
(Additional file 2: Figure S17). As previously described
[27], a threshold for defining “detectable” 5hmC was cal-
culated from the 95th percentile of the negative beta
values (which result from technical noise), and beta
values >0.0357 were considered to represent reliably de-
tected levels of 5hmC. Probes not passing this threshold
in at least one sample (n = 103,501 of the 411,325 sites
passing quality control) were removed (Additional file 1:
Table S1); leaving 307,824 probes (298,972 = autosomal)
for further analysis.
Identification of differentially modified position as (DMPs)
and regions (DMRs) associated with human brain
development
A multiple linear regression model was used to identify
changes in 5mC and 5hmC at specific sites associated
with brain development and gender. We fitted models of
the form;
oxBS∼DPCþ gender
BS−oxBS∼DPCþ gender
Autosomal probes (n = 298,972) were considered
significantly associated with brain development if they
passed a Bonferroni-corrected significance threshold of P-
value <1.67E-07. Autosomal and X-chromosome probes
(n = 307,810) were considered to be significantly associ-
ated with sex if they passed a Bonferroni-corrected signifi-
cance threshold of P-value <1.62E-07. To identify DMRs,
we used the Python module comb-p [33] to group spatially
correlated DMPs (seed P-value <1.00E-04, minimum of 3
probes, Šidák-corrected P-value <0.05) at a maximum
distance of 500 bp. DMR P-values were corrected for
multiple testing using Šidák correction which corrects the
combined P-value for na/nr tests, where na is the total
number of probes tested in the initial dataset and nr the
number of probes in the given region.
Identifying different slopes for changes in 5mC and 5hmC
across brain development
To test for significantly different relationships across
development between 5mC and 5hmC we ran a mixed
effects regression model. This model was fit for the
combined dataset of 5mC and 5hmC. An indicator vari-
able to denote which modification the data point was
measuring was included to prevent differences in
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absolute levels being misidentified as significantly differ-
ent slopes with an interaction between this indicator and
age to identify significantly different slope coefficients.
Because the DNA modifications were quantified in the
same individuals, we expect the DNA methylation and
DNA hydroxymethylation values to be correlated, there-
fore individual was included as a random effect and
other covariates as fixed effects. The fixed effects part of
this model is specified here:
oxBS=ðBS−oxBSÞ
e
DPCþ genderþ IndoxBS=ðBS−oxBSÞ
þDPC  IndoxBS=ðBS−oxBSÞ
Weighted gene co-modification network analysis
Weighted gene co-modification network analysis
(WGCNA) was used to identify modules of highly
co-hydroxymethylated probes [36]. Modules were identi-
fied from their pairwise correlations, using a signed
block-wise network construction at power 5 with a
merging threshold of 0.30 and n = 1000 minimum
probes. Modules were assigned a color name, and a
weighted average-hydroxymethylation profile, known as
a module eigengene (ME), was calculated for each.
Correlations between the MEs and the phenotypic traits
(DPC, sex) were used to identify modules associated
with these traits. The relationship between each probe
and each module was assessed through calculation of
module membership (MM), the absolute correlation
between a probe’s DNA hydroxymethylation status
and the ME, allowing the identification of the subset
of probes with the strongest membership to each
module. Probe significance (PS), the absolute value of
correlation between each probe and phenotypic trait,
was calculated to quantify the association of probes
with DPC. To assess the biological meaning of
modules associated with DPC and sex, genes associ-
ated with the top 1000 probes ranked by MM were
extracted and assessed using pathway and gene
ontology analysis.
Gene ontology analysis
A gene list was derived from the DMPs using Illumina’s
gene annotation. This annotation, which comes via
UCSC, is based on overlap with RefSeq genes plus
1500 bp of upstream sequence. Where probes were not
annotated to any gene (i.e. in the case of intergenic loca-
tions) they were omitted from this analysis, and where
probes were annotated to multiple genes all were in-
cluded. A logistic regression approach was used to test if
genes in this list predicted pathway membership, while
controlling for the number of probes that passed quality
control (i.e. were tested) annotated to each gene.
Pathways were downloaded from the GO website
(http://geneontology.org/) and mapped to genes includ-
ing all parent ontology terms. All genes with at least one
450 K probe annotated and mapped to at least one GO
pathway were considered. Pathways were filtered to
those containing between 10 and 2000 genes. After ap-
plying this method to all pathways, the list of significant
pathways (P-value <0.05) was refined by grouping to
control for the effect of overlapping genes. This was
achieved by taking the most significant pathway, and
retesting all remaining significant pathways while
controlling additionally for the best term. If the test
genes no longer predicted the pathway, the term was
said to be explained by the more significant pathway,
and hence these pathways were grouped together. This
algorithm was repeated, taking the next most signifi-
cant term, until all pathways were considered as the
most significant or found to be explained by a more
significant term.
DNA methylation and DNA hydroxymethylation
quantitative trait loci
Genotype data was available for 64 of the 71 samples;
these were assessed for DNA methylation quantitative
trait loci (mQTL) and DNA hydroxymethylation quanti-
tative trait loci (hmQTL). The genetic data was profiled
on the Illumina HumanOmniExpress BeadChip (Illu-
mina) chip and imputed as described previously [37].
SNPs were then filtered with PLINK [47] excluding vari-
ants with >1% missing values, Hardy-Weinburg equilib-
rium P-value <0.0001 or a minor allele frequency of
<5%. Subsequently, SNPs were also filtered so that each
of the three genotype groups with 0, 1, or 2 minor alleles
(or two genotype groups in the case of rarer SNPs with
0 or 1 minor allele) had a minimum of 5 observations.
An additive linear model was fitted using MatrixEQTL
[48] to test if the number of alleles (coded 0, 1, or 2)
predicted 5mC or 5hmC at each site, including covari-
ates for age, sex, and the first two principal components
from the genotype data. To test for a significantly differ-
ent genetic effect on 5hmC compared to 5mC, all sig-
nificant mQTL and hmQTL were subsequently tested
for heterogeneous effects. To this end, a multi-level
model was fitted across the data for both modifications
using the R packages lme4 [49] and lmerTest [50]. In
these models genotype, age, sex, the first two principal
components and an indicator variable to distinguish
5mC from 5hmC measurements were included as fixed
effects, and individual was included as a random effect.
Two models with and without an interaction term
between genotype and the modification indicator
variable were fitted for each QTL and the heterogeneity
P-value was calculated from an ANOVA comparing
these two models.
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